Results of Treatment of Grades IV and V Vesicoureteral Reflux with Endoscopic Injection of Polyacrylate Polyalcohol Copolymer
Open Access
- 1 January 2013
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 1, 65393
Abstract
Purpose: Here we report the results of a review of a prospectively maintained database of the use polyacrylate polyalcohol copolymer (PPC) injection to correct grades IV and V VUR. Materials and methods: All children with grades IV and V primary VUR that presented with febrile urinary tract infection while on prophylaxis, in a three -year period, were treated with a subureteral injection of PPC. Institutional ethical approval was obtained. Exclusion criteria were incomplete bladder emptying documented on videourodynamic study, ureteral duplication, paraureteral diverticula and poor ureteral emptying observed during fluoroscopy and previous open surgical or endoscopic treatment. Pre- and post-operative evaluation included urinalysis, renal and bladder ultrasonography, DMSA scan and videourodynamic studies. Results: 33 children (36 renal units) were included with a median age of 57 months (range 7 to 108). There were 18 males and 15 girls. 30 renal units had grade IV and 6 grade V VUR. Median follow-up time was 32 months (range 7 to 58). Reflux was cured in 32/36 renal units with the first injection, but another 2 patients were reimplanted because of dilatation. Complications included early urinary tract infection in 7 children, transient lower urinary tract symptoms in 5 children. Progressive ureteral dilatation was noted in 4 children and was treated with insertion of a double J stent. Two of these children eventually required an ureteroneocystostomy. Conclusions: The use of PPC to treat grades IV and V vesicoureteral reflux in young children has an overall success rate of 83,3%. Persistent ureteral dilatation was present in 11% associated with high injection volume. Future studies will attempt to maintain a high success rate reducing the volume of injection and the incidence of dilatation.Keywords
This publication has 18 references indexed in Scilit:
- Ureteral obstruction following injection of dextranomer/hyaluronic acid copolymer: An infrequent but relevant complicationJournal of Pediatric Urology, 2012
- Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in ChildrenJournal of Urology, 2010
- Long-term antibiotics for the prevention of recurrent urinary tract infection in children: a systematic review and meta-analysisArchives of Disease in Childhood, 2010
- Long-Term Followup of Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux: Late Failure Warrants Continued FollowupJournal of Urology, 2009
- Febrile Urinary Tract Infections in Children With an Early Negative Voiding Cystourethrogram After Treatment of Vesicoureteral Reflux With Dextranomer/Hyaluronic AcidJournal of Urology, 2008
- Minimally Invasive Treatment of Vesicoureteral Reflux with Endoscopic Injection of Dextranomer/Hyaluronic Acid Copolymer: The Children’s Hospitals of Atlanta ExperienceJournal of Urology, 2003
- Endoscopic Treatment of Vesico-Ureteral Reflux: Twelve Years’ ExperienceUrologia Internationalis, 2001
- POLYTETRAFLUOROETHYLENE GIANT GRANULOMA AND ADENOPATHY: LONG-TERM COMPLICATIONS FOLLOWING SUBURETERAL POLYTETRAFLUOROETHYLENE INJECTION FOR THE TREATMENT OF VESICOURETERAL REFLUX IN CHILDRENJournal of Urology, 1997
- Evaluation of Polydimethylsiloxane as an Alternative in the Endoscopic Treatment of Vesicoureteral RefluxJournal of Urology, 1994
- TREATMENT OF VESICORENAL REFLUX BY TRANS-URETHRAL TEFLON-INJECTION1981